関連する実験動画
Updated: Feb 20, 2026

10:14
Retroviral Transduction of T-cell Receptors in Mouse T-cells
Published on: October 22, 2010
36.2K
調節性T細胞における二重CD8およびTCR編集は,HLA-A2制限された組織特異的ホーミングを媒介する
Raphaël Porret1, Fanny Lebreton2, Eleonora Pace1
1Division of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne CH-1005, Switzerland.
Molecular therapy : the journal of the American Society of Gene Therapy
|February 19, 2026
まとめ
研究者らは,調節性T細胞 (Tregs) を1型糖尿病 (T1D) の臓小島を標的とするように設計した. このアプローチはTregの浸透を改善し,T1D治療の有望な新しい道を提供しました.
科学分野:
- 免疫学 免疫学とは
- エンドクリノロジー エンドクリノロジー
- 細胞療法 細胞療法
背景:
- 1型糖尿病 (T1D) は,臓のベータ細胞の自己免疫破壊を伴う.
- 島のMHCクラスI抗原が過剰発現すると,CD8+T細胞を惹きつけ,T1Dの病原性を誘発する.
- 現在のTreg療法は,小島特有の標的化が欠如しており,有効性を制限しています.
研究 の 目的:
- 島根抗原の特異性を有する調節性T細胞 (Tregs) を設計する.
- T1D治療を改善するために,Tregが臓の小島に浸透するのを強化する.
- エンジニアリングされたTregsの機能と取引を検証するために.
主な方法:
- TRAC/CD4遺伝子のデュアルロカスホモロジー指向編集により,Tregsに小島特有のTCRを導入します.
- ZnT8とIGRPの小島オートアンチゲンを標的にする2つのHLA-A2制限のTCRの機能的検証.
- エンジニアリングされたTregフェノタイプ,抑制機能,およびin vivo移行の評価.
主要な成果:
- エンジニアリングされたCD4-to-CD8 TCR Tregsは,安定したフェノタイプとインビトロ抑制機能を維持しました.
- TCR特異性は,ペプチド特異性とCD8共受容体の機能依存性に影響した.
- エンジニアリングされたTregsは,共同受容体依存の移住を vivo で実証し,標的組織への帰着を示しています.
結論:
- TCRの特異性は,Tregの密輸を,臓の小島のような組織をターゲットにするために決定的に重要です.
- Tregの特異性を小島抗原に転向させることで,それらの浸透を高めることができます.
- この戦略は,T1Dに対するTregベースの治療法の有効性を改善する可能性を秘めています.
関連する概念動画
T Cell Activation and Clonal Selection
16.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.5K
T Cell Types and Functions
2.7K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.7K
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
Diversity of Antigen Receptors
1.7K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.7K
Cell-mediated Immune Responses
84.6K
Overview
84.6K

